Attached files

file filename
EX-31.1 - CERTIFICATION BY MARTIN A. MATTINGLY AS CEO - SYNAGEVA BIOPHARMA CORPdex311.htm
EX-32.2 - SECTION 1350 CERTIFICATION BY ANDREW L. GRAHAM AS CFO - SYNAGEVA BIOPHARMA CORPdex322.htm
EX-31.2 - CERTIFICATION BY ANDREW L. GRAHAM AS CFO - SYNAGEVA BIOPHARMA CORPdex312.htm
EX-32.1 - SECTION 1350 CERTIFICATION BY MARTIN A. MATTINGLY AS CEO - SYNAGEVA BIOPHARMA CORPdex321.htm
10-K - FORM 10-K - SYNAGEVA BIOPHARMA CORPd10k.htm
EX-23.1 - CONSENT OF ERNST AND YOUNG LLP - SYNAGEVA BIOPHARMA CORPdex231.htm

Exhibit 23.2

 

Consent of Independent Registered Public Accounting Firm

 

The Board of Directors

Trimeris, Inc.:

 

We consent to the incorporation by reference in the registration statements (No. 333-44145, No. 333-64064, No. 333-66401, No. 333-74304, No. 333-90377, No. 333-107508, No. 333-129600, No. 333-138807, No. 333-147430, and 333-147431) on Forms S-8 of Trimeris, Inc. of our report dated March 12, 2009, except with respect to the adoption of FASB ASC Topic 808, Collaborative Arrangements, (as discussed in adoption of new accounting standards of note 1 and paragraph 8 of note 8 to the December 31, 2009 financial statements), as to which the date is as of March 16, 2010, with respect to the balance sheet of Trimeris, Inc. as of December 31, 2008, and the related statements of operations, stockholders’ equity, and cash flows for each of the years in the two-year period then ended, which appears in the December 31, 2009 annual report on Form 10-K of Trimeris, Inc.

 

As discussed in adoption of new accounting standards of note 1 and in paragraph 8 of note 8 to the December 31, 2009 financial statements, the Company adopted the provisions of FASB ASC Topic 808, Collaborative Arrangements, as of January 1, 2009 and, accordingly, adjusted the previously issued statements of operations for each of the years in the two-year period ended December 31, 2008.

 

KPMG LLP

Raleigh, North Carolina

 

March 12, 2009, except with respect to the adoption of FASB ASC Topic 808, Collaborative Arrangements, (as discussed in adoption of new accounting standards of note 1 and paragraph 8 of note 8 to the December 31, 2009 financial statements), as to which the date is as of March 16, 2010